Key result
Splicing modulator E7107 partially restores zebrafish hematopoietic stem cells diminished by khdrbs1 mutagenesis.
Why the study?
Regulators of endothelial-to-hematopoietic transition, through which definitive hematopoietic stem and progenitor cells arise, remain incompletely understood.
Identification of Khdrbs1 as a critical regulator of endothelial-to-hematopoietic transition via alternative splicing provides deeper understanding of cell fate tuning.
Khdrbs1 splicing may tune EHT in zebrafish; leaves open conservation and therapeutic relevance in mammalian hematopoiesis.
SUMMARY Definitive hematopoietic stem and progenitor cells (HSPCs) arise through an endothelial-to-hematopoietic transition (EHT), whereby endothelial cells (ECs) acquire a hemogenic fate (HE) and convert to HSPCs. EHT regulators remain incompletely understood. Utilizing published RNA-seq data of ECs, HE/HSPCs, and HSPCs, we defined the alternative splicing landscape of zebrafish EHT and potential RNA binding proteins governing the process. Employing an F0 CRISPR-Cas9 mediated mutagenesis screen, we identified zebrafish homologs of KHDRBS1 as critical for embryonic HSPC formation. Mutagenesis of khdrbs1a/b led to diminished HSPCs and a profound lineage shift in differentiated cells, with the greatest decrease observed in rag+ T-cells. Treatment of mutagenized embryos with the splicing modulator E7107 partially restored HSPCs to near wildtype levels indicating Khdrbs1 splicing regulation drives EHT. Consistently, Khdrbs1 binding motifs were the only ones enriched in EHT alternative splicing events. Identification of EHT-specific splicing regulation provides a deeper understanding of cell fate tuning by splicing.
No takes yet. Share an insight, caveat, or question.
Karp et al. (2024) studied Hematopoietic stem and progenitor cell emergence. CRISPR-Cas9 mediated mutagenesis of khdrbs1a/b and E7107 treatment vs. Wildtype/control was evaluated on Hematopoietic stem and progenitor cell formation. Mutagenesis of zebrafish khdrbs1a/b diminished hematopoietic stem and progenitor cells, which was partially restored by the splicing modulator E7107, indicating Khdrbs1 splicing regulation drives EHT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: